Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan.
![Stryker logo](/files/LOGO/310764-SYK.png)
Company profile
Ticker
SYK
Exchange
Website
CEO
Kevin Lobo
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
2Hip Holdings SAS • Aïmago SA • Alcott Indemnity Company • Arrinex, Inc. • Berchtold + Fritz GmbH • Berchtold Corporation • Berchtold GmbH & Co. KG • Berchtold Holding Switzerland GmbH • BioMimetic Therapeutics USA, Inc. • BioMimetic Therapeutics, LLC ...
IRS number
381239739
SYK stock data
Latest filings (excl ownership)
SD
Conflict minerals disclosure
24 May 24
8-K
Submission of Matters to a Vote of Security Holders
14 May 24
10-Q
2024 Q1
Quarterly report
1 May 24
8-K
Stryker Reports First Quarter 2024 Operating Results
30 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Mar 24
DEF 14A
Definitive proxy
26 Mar 24
10-K
2023 FY
Annual report
14 Feb 24
8-K
Stryker Reports 2023 Operating Results and 2024 Outlook
30 Jan 24
CERT
Certification of approval for exchange listing
12 Dec 23
8-A12B
Registration of securities on exchange
11 Dec 23
Transcripts
SYK
Earnings call transcript
2024 Q1
30 Apr 24
SYK
Earnings call transcript
2023 Q4
30 Jan 24
SYK
Earnings call transcript
2023 Q3
2 Nov 23
SYK
Earnings call transcript
2023 Q2
3 Aug 23
SYK
Earnings call transcript
2023 Q1
1 May 23
SYK
Earnings call transcript
2023 Q1
1 May 23
SYK
Earnings call transcript
2022 Q4
31 Jan 23
SYK
Earnings call transcript
2022 Q3
1 Nov 22
SYK
Earnings call transcript
2022 Q2
27 Jul 22
SYK
Earnings call transcript
2022 Q1
29 Apr 22
Latest ownership filings
4
Glenn S Boehnlein
3 Jul 24
4
Robert S Fletcher
23 May 24
144
Notice of proposed sale of securities
22 May 24
4
Glenn S Boehnlein
16 May 24
144
Notice of proposed sale of securities
15 May 24
4
Rajeev Suri
13 May 24
4
RONDA E STRYKER
13 May 24
4
Tatum Lisa M Skeete
13 May 24
4
Andrew K Silvernail
13 May 24
4
Rachel Ruggeri
13 May 24
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 2.33 bn | 2.33 bn | 2.33 bn | 2.33 bn | 2.33 bn | 2.33 bn |
Cash burn (monthly) | 213.67 mm | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 826.07 mm | n/a | n/a | n/a | n/a | n/a |
Cash remaining | 1.50 bn | n/a | n/a | n/a | n/a | n/a |
Runway (months of cash) | 7.0 | n/a | n/a | n/a | n/a | n/a |
Institutional ownership, Q1 2024
75.1% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1900 |
Opened positions | 428 |
Closed positions | 121 |
Increased positions | 605 |
Reduced positions | 592 |
13F shares | Current |
---|---|
Total value | 93.99 tn |
Total shares | 285.93 mm |
Total puts | 707.86 k |
Total calls | 1.19 mm |
Total put/call ratio | 0.6 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 31.46 mm | $11.26 tn |
BLK Blackrock | 26.24 mm | $9.39 tn |
Greenleaf Trust | 18.60 mm | $6.66 tn |
STT State Street | 14.35 mm | $5.15 tn |
T. Rowe Price | 11.88 mm | $4.25 bn |
Wellington Management | 10.84 mm | $3.88 tn |
Capital Research Global Investors | 9.98 mm | $3.57 tn |
JPM JPMorgan Chase & Co. | 8.65 mm | $3.10 tn |
Geode Capital Management | 6.58 mm | $2.35 tn |
FMR | 6.05 mm | $2.16 tn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jul 24 | Boehnlein Glenn S | Common Stock | Payment of exercise | Dispose F | No | No | 336.5 | 17,160 | 5.77 mm | 22,852 |
2 Jul 24 | Boehnlein Glenn S | Common Stock | Option exercise | Acquire M | No | No | 122.51 | 25,000 | 3.06 mm | 40,012 |
2 Jul 24 | Boehnlein Glenn S | Employee Stock Option granted 2/8/2017 Common Stock | Option exercise | Dispose M | No | No | 122.51 | 25,000 | 3.06 mm | 15,815 |
22 May 24 | Fletcher Robert S | Common Stock | Sell | Dispose S | No | No | 332.9885 | 2,007 | 668.31 k | 8,896 |
15 May 24 | Boehnlein Glenn S | Common Stock | Sell | Dispose S | No | No | 327.6516 | 10,000 | 3.28 mm | 15,012 |
9 May 24 | Brainerd Mary K | Common Stock | Grant | Acquire A | No | No | 0 | 653 | 0.00 | 6,468 |
News
10 Health Care Stocks Whale Activity In Today's Session
26 Jul 24
Peering Into Stryker's Recent Short Interest
24 Jul 24
$1000 Invested In Stryker 10 Years Ago Would Be Worth This Much Today
23 Jul 24
Catalent Expands Its Facility Capabilities in Germany
17 Jul 24
Morgan Stanley Maintains Equal-Weight on Stryker, Raises Price Target to $350
15 Jul 24
Press releases
Stryker joins Atrium Health affiliate IRCAD North America to advance surgical training and education
18 Jun 24
Stryker releases LIFEPAK 35 monitor/defibrillator
4 Jun 24
Stryker Announces Definitive Agreement to Acquire Artelon, Inc., Offering a Range of Soft Tissue Fixation Solutions for Orthopaedic Surgeons
3 Jun 24